Discrimination between Pancreatic Cancer, Pancreatitis and Healthy Controls Using Urinary Polyamine Panel

Backround Polyamines play an important role in cellular proliferation, and the change in polyamine metabolism is reported in various cancers. We searched for urinary polyamine signature for distinguishing between pancreatic cancer, premalignant lesions of the pancreas (PLP), acute and chronic pancre...

Full description

Bibliographic Details
Main Authors: Samuli I. Nissinen MD, Markus Venäläinen MD, Pekka Kumpulainen DSc, Antti Roine MD, PhD, Merja R. Häkkinen PhD, Jouko Vepsäläinen PhD, Niku Oksala MD, PhD, Tuomo Rantanen MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2021-10-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/10732748211039762
_version_ 1818331366679379968
author Samuli I. Nissinen MD
Markus Venäläinen MD
Pekka Kumpulainen DSc
Antti Roine MD, PhD
Merja R. Häkkinen PhD
Jouko Vepsäläinen PhD
Niku Oksala MD, PhD
Tuomo Rantanen MD, PhD
author_facet Samuli I. Nissinen MD
Markus Venäläinen MD
Pekka Kumpulainen DSc
Antti Roine MD, PhD
Merja R. Häkkinen PhD
Jouko Vepsäläinen PhD
Niku Oksala MD, PhD
Tuomo Rantanen MD, PhD
author_sort Samuli I. Nissinen MD
collection DOAJ
description Backround Polyamines play an important role in cellular proliferation, and the change in polyamine metabolism is reported in various cancers. We searched for urinary polyamine signature for distinguishing between pancreatic cancer, premalignant lesions of the pancreas (PLP), acute and chronic pancreatitis, and controls. Methods Patients and controls were prospectively recruited in three Finnish hospitals between October 2013 and June 2016. The patients provided a urine sample at the time of the diagnosis. The panel of 14 polyamines was obtained in a single run with mass spectrometry. The polyamine concentrations were analysed with quadratic discriminant analysis and cross-validated with leave-one-out cross-validation. Results Sixty-eight patients with pancreatic cancer, 36 with acute pancreatitis, 18 with chronic pancreatitis and 7 with PLP were recruited, as were 53 controls. The combination of 4 polyamines – acetylputrescine, diacetylspermidine, N 8 -acetylspermidine and diacetylputrescine – distinguished pancreatic cancer and PLP from controls (sensitivity = 94%, specificity = 68% and AUC = 0.88). The combination of diacetylspermidine, N8-acetylspermidine and diacetylspermine distinguished acute pancreatitis from controls (sensitivity = 94%, specificity = 92%, AUC = 0.98). The combination of acetylputrescine, diacetylspermidine and diacetylputrescine distinguished chronic pancreatitis from controls (sensitivity = 98%, specificity = 71%, AUC = 0.93). Conclusions Optimally selected urinary polyamine panels discriminate between pancreatic cancer and controls, as well as between acute and chronic pancreatitis and controls.
first_indexed 2024-12-13T13:18:43Z
format Article
id doaj.art-d776371d2e40453f82fb01010496060c
institution Directory Open Access Journal
issn 1073-2748
language English
last_indexed 2024-12-13T13:18:43Z
publishDate 2021-10-01
publisher SAGE Publishing
record_format Article
series Cancer Control
spelling doaj.art-d776371d2e40453f82fb01010496060c2022-12-21T23:44:28ZengSAGE PublishingCancer Control1073-27482021-10-012810.1177/10732748211039762Discrimination between Pancreatic Cancer, Pancreatitis and Healthy Controls Using Urinary Polyamine PanelSamuli I. Nissinen MDMarkus Venäläinen MDPekka Kumpulainen DScAntti Roine MD, PhDMerja R. Häkkinen PhDJouko Vepsäläinen PhDNiku Oksala MD, PhDTuomo Rantanen MD, PhDBackround Polyamines play an important role in cellular proliferation, and the change in polyamine metabolism is reported in various cancers. We searched for urinary polyamine signature for distinguishing between pancreatic cancer, premalignant lesions of the pancreas (PLP), acute and chronic pancreatitis, and controls. Methods Patients and controls were prospectively recruited in three Finnish hospitals between October 2013 and June 2016. The patients provided a urine sample at the time of the diagnosis. The panel of 14 polyamines was obtained in a single run with mass spectrometry. The polyamine concentrations were analysed with quadratic discriminant analysis and cross-validated with leave-one-out cross-validation. Results Sixty-eight patients with pancreatic cancer, 36 with acute pancreatitis, 18 with chronic pancreatitis and 7 with PLP were recruited, as were 53 controls. The combination of 4 polyamines – acetylputrescine, diacetylspermidine, N 8 -acetylspermidine and diacetylputrescine – distinguished pancreatic cancer and PLP from controls (sensitivity = 94%, specificity = 68% and AUC = 0.88). The combination of diacetylspermidine, N8-acetylspermidine and diacetylspermine distinguished acute pancreatitis from controls (sensitivity = 94%, specificity = 92%, AUC = 0.98). The combination of acetylputrescine, diacetylspermidine and diacetylputrescine distinguished chronic pancreatitis from controls (sensitivity = 98%, specificity = 71%, AUC = 0.93). Conclusions Optimally selected urinary polyamine panels discriminate between pancreatic cancer and controls, as well as between acute and chronic pancreatitis and controls.https://doi.org/10.1177/10732748211039762
spellingShingle Samuli I. Nissinen MD
Markus Venäläinen MD
Pekka Kumpulainen DSc
Antti Roine MD, PhD
Merja R. Häkkinen PhD
Jouko Vepsäläinen PhD
Niku Oksala MD, PhD
Tuomo Rantanen MD, PhD
Discrimination between Pancreatic Cancer, Pancreatitis and Healthy Controls Using Urinary Polyamine Panel
Cancer Control
title Discrimination between Pancreatic Cancer, Pancreatitis and Healthy Controls Using Urinary Polyamine Panel
title_full Discrimination between Pancreatic Cancer, Pancreatitis and Healthy Controls Using Urinary Polyamine Panel
title_fullStr Discrimination between Pancreatic Cancer, Pancreatitis and Healthy Controls Using Urinary Polyamine Panel
title_full_unstemmed Discrimination between Pancreatic Cancer, Pancreatitis and Healthy Controls Using Urinary Polyamine Panel
title_short Discrimination between Pancreatic Cancer, Pancreatitis and Healthy Controls Using Urinary Polyamine Panel
title_sort discrimination between pancreatic cancer pancreatitis and healthy controls using urinary polyamine panel
url https://doi.org/10.1177/10732748211039762
work_keys_str_mv AT samuliinissinenmd discriminationbetweenpancreaticcancerpancreatitisandhealthycontrolsusingurinarypolyaminepanel
AT markusvenalainenmd discriminationbetweenpancreaticcancerpancreatitisandhealthycontrolsusingurinarypolyaminepanel
AT pekkakumpulainendsc discriminationbetweenpancreaticcancerpancreatitisandhealthycontrolsusingurinarypolyaminepanel
AT anttiroinemdphd discriminationbetweenpancreaticcancerpancreatitisandhealthycontrolsusingurinarypolyaminepanel
AT merjarhakkinenphd discriminationbetweenpancreaticcancerpancreatitisandhealthycontrolsusingurinarypolyaminepanel
AT joukovepsalainenphd discriminationbetweenpancreaticcancerpancreatitisandhealthycontrolsusingurinarypolyaminepanel
AT nikuoksalamdphd discriminationbetweenpancreaticcancerpancreatitisandhealthycontrolsusingurinarypolyaminepanel
AT tuomorantanenmdphd discriminationbetweenpancreaticcancerpancreatitisandhealthycontrolsusingurinarypolyaminepanel